Christie Jaryd R, Daher Omar, Abdelrazek Mohamed, Romine Perrin E, Malthaner Richard A, Qiabi Mehdi, Nayak Rahul, Napel Sandy, Nair Viswam S, Mattonen Sarah A
Western University, Department of Medical Biophysics, London, Ontario, Canada.
London Regional Cancer Program, Baines Imaging Research Laboratory, London, Ontario, Canada.
J Med Imaging (Bellingham). 2022 Nov;9(6):066001. doi: 10.1117/1.JMI.9.6.066001. Epub 2022 Nov 8.
We developed a model integrating multimodal quantitative imaging features from tumor and nontumor regions, qualitative features, and clinical data to improve the risk stratification of patients with resectable non-small cell lung cancer (NSCLC).
We retrospectively analyzed 135 patients [mean age, 69 years (43 to 87, range); 100 male patients and 35 female patients] with NSCLC who underwent upfront surgical resection between 2008 and 2012. The tumor and peritumoral regions on both preoperative CT and FDG PET-CT and the vertebral bodies L3 to L5 on FDG PET were segmented to assess the tumor and bone marrow uptake, respectively. Radiomic features were extracted and combined with clinical and CT qualitative features. A random survival forest model was developed using the top-performing features to predict the time to recurrence/progression in the training cohort ( ), validated in the testing cohort ( ) using the concordance, and compared with a stage-only model. Patients were stratified into high- and low-risks of recurrence/progression using Kaplan-Meier analysis.
The model, consisting of stage, three wavelet texture features, and three wavelet first-order features, achieved a concordance of 0.78 and 0.76 in the training and testing cohorts, respectively, significantly outperforming the baseline stage-only model results of 0.67 ( ) and 0.60 ( ), respectively. Patients at high- and low-risks of recurrence/progression were significantly stratified in both the training ( ) and the testing ( ) cohorts.
Our radiomic model, consisting of stage and tumor, peritumoral, and bone marrow features from CT and FDG PET-CT significantly stratified patients into low- and high-risk of recurrence/progression.
我们开发了一种整合肿瘤和非肿瘤区域的多模态定量成像特征、定性特征及临床数据的模型,以改善可切除非小细胞肺癌(NSCLC)患者的风险分层。
我们回顾性分析了2008年至2012年间接受 upfront 手术切除的135例NSCLC患者[平均年龄69岁(43至87岁,范围);男性患者100例,女性患者35例]。对术前CT和FDG PET-CT上的肿瘤及瘤周区域以及FDG PET上的L3至L5椎体进行分割,分别评估肿瘤和骨髓摄取情况。提取放射组学特征,并将其与临床和CT定性特征相结合。使用表现最佳的特征开发随机生存森林模型,以预测训练队列中的复发/进展时间( ),在测试队列( )中使用一致性进行验证,并与仅基于分期的模型进行比较。使用Kaplan-Meier分析将患者分层为复发/进展的高风险和低风险。
该模型由分期、三个小波纹理特征和三个小波一阶特征组成,在训练队列和测试队列中的一致性分别为0.78和0.76,显著优于仅基于分期的基线模型结果,分别为0.67( )和0.60( )。复发/进展高风险和低风险的患者在训练队列( )和测试队列( )中均有显著分层。
我们的放射组学模型由分期以及来自CT和FDG PET-CT的肿瘤、瘤周和骨髓特征组成,可将患者显著分层为复发/进展的低风险和高风险。